Global Medical REIT (GMRE)
(Delayed Data from NYSE)
$8.29 USD
+0.18 (2.22%)
Updated Apr 29, 2024 04:00 PM ET
After-Market: $8.28 -0.01 (-0.12%) 5:06 PM ET
2-Buy of 5 2
B Value F Growth D Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$8.29 USD
+0.18 (2.22%)
Updated Apr 29, 2024 04:00 PM ET
After-Market: $8.28 -0.01 (-0.12%) 5:06 PM ET
2-Buy of 5 2
B Value F Growth D Momentum D VGM
Zacks News
Global Medical REIT (GMRE) Q2 FFO Meet Estimates
by Zacks Equity Research
Global Medical REIT (GMRE) delivered FFO and revenue surprises of 0.00% and 3.01%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?
GMRE or LAMR: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
GMRE vs. LAMR: Which Stock Is the Better Value Option?
GMRE vs. LAMR: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
GMRE vs. LAMR: Which Stock Is the Better Value Option?
Top Ranked Growth Stocks to Buy for July 19th
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, July 19th:
Top Ranked Growth Stocks to Buy for January 30th
by Zacks Equity Research
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, January 30th:
Top Ranked Growth Stocks to Buy for January 26th
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, January 26th:
Top Ranked Growth Stocks to Buy for January 10th
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, January 10th:
Top Ranked Growth Stocks to Buy for December 12th
by Zacks Equity Research
Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, December 12th:
Surging Earnings Estimates Signal Good News for Global Medical REIT (GMRE)
by Zacks Equity Research
Global Medical REIT (GMRE) is seeing solid earnings estimate revisions, and the stock is showing decent short-term momentum as well.